Proteogenomic analysis of Candida glabrata using high resolution mass spectrometry.

Candida glabrata is a common opportunistic human pathogen leading to significant mortality in immunosuppressed and immunodeficient individuals. We carried out proteomic analysis of C. glabrata using high resolution Fourier transform mass spectrometry with MS resolution of 60,000 and MS/MS resolution of 7500. On the basis of 32,453 unique peptides identified from 118,815 peptide-spectrum matches, we validated 4421 of the 5283 predicted protein-coding genes (83%) in the C. glabrata genome. Further, searching the tandem mass spectra against a six frame translated genome database of C. glabrata resulted in identification of 11 novel protein coding genes and correction of gene boundaries for 14 predicted gene models. A subset of novel protein-coding genes and corrected gene models were validated at the transcript level by RT-PCR and sequencing. Our study illustrates how proteogenomic analysis enabled by high resolution mass spectrometry can enrich genome annotation and should be an integral part of ongoing genome sequencing and annotation efforts.

[1]  Nandini A. Sahasrabuddhe,et al.  A proteogenomic analysis of Anopheles gambiae using high-resolution Fourier transform mass spectrometry. , 2011, Genome research.

[2]  M. Mann,et al.  System-wide Perturbation Analysis with Nearly Complete Coverage of the Yeast Proteome by Single-shot Ultra HPLC Runs on a Bench Top Orbitrap* , 2011, Molecular & Cellular Proteomics.

[3]  Werner Sieghart,et al.  Deep Amino Acid Sequencing of Native Brain GABAA Receptors Using High-Resolution Mass Spectrometry , 2011, Molecular & Cellular Proteomics.

[4]  David W Williams,et al.  Adherence and biofilm formation of non-Candida albicans Candida species. , 2011, Trends in microbiology.

[5]  Sven Nahnsen,et al.  Mass spectrometry at the interface of proteomics and genomics. , 2011, Molecular bioSystems.

[6]  V. Bafna,et al.  Proteogenomics to discover the full coding content of genomes: a computational perspective. , 2010, Journal of proteomics.

[7]  Nandini A. Sahasrabuddhe,et al.  Comparative Proteomic Analysis of Candida albicans and Candida glabrata , 2010, Clinical Proteomics.

[8]  Y. Abiko,et al.  Proteomics of drug resistance in Candida glabrata biofilms , 2010, Proteomics.

[9]  L. Foster,et al.  Quantitative analysis of proteome coverage and recovery rates for upstream fractionation methods in proteomics. , 2010, Journal of proteome research.

[10]  Alistair J. P. Brown,et al.  Impact of the transcriptional regulator, Ace2, on the Candida glabrata secretome , 2010, Proteomics.

[11]  K. Kuchler,et al.  Candida glabrata Persistence in Mice Does Not Depend on Host Immunosuppression and Is Unaffected by Fungal Amino Acid Auxotrophy , 2009, Infection and Immunity.

[12]  E. Hafen,et al.  Identification and Functional Characterization of N-Terminally Acetylated Proteins in Drosophila melanogaster , 2009, PLoS biology.

[13]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[14]  David James Sherman,et al.  Génolevures: protein families and synteny among complete hemiascomycetous yeast proteomes and genomes , 2008, Nucleic Acids Res..

[15]  Akhilesh Pandey,et al.  A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. , 2008, Journal of proteome research.

[16]  M. Pfaller,et al.  Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. , 2008, Diagnostic microbiology and infectious disease.

[17]  Akhilesh Pandey,et al.  Quantitative proteomics using stable isotope labeling with amino acids in cell culture , 2008, Nature Protocols.

[18]  David Haussler,et al.  Using native and syntenically mapped cDNA alignments to improve de novo gene finding , 2008, Bioinform..

[19]  V. Vincek,et al.  Candida glabrata infection in gastric carcinoma patient mimicking cutaneous histoplasmosis. , 2008, Dermatology online journal.

[20]  Alistair J. P. Brown,et al.  Proteomic analysis of the pH response in the fungal pathogen Candida glabrata , 2008, Proteomics.

[21]  M. Mann,et al.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.

[22]  A. Dongari-Bagtzoglou,et al.  Candida glabrata: an emerging oral opportunistic pathogen. , 2007, Journal of dental research.

[23]  P. D. Rogers,et al.  Proteomic analysis of experimentally induced azole resistance in Candida glabrata. , 2006, The Journal of antimicrobial chemotherapy.

[24]  Akhilesh Pandey,et al.  Genome annotation of Anopheles gambiae using mass spectrometry-derived data , 2005, BMC Genomics.

[25]  F. Dalle,et al.  Biological consequences of petite mutations in Candida glabrata. , 2005, The Journal of antimicrobial chemotherapy.

[26]  Ken Haynes,et al.  Proteomic changes associated with inactivation of the Candida glabrata ACE2 virulence‐moderating gene , 2005, Proteomics.

[27]  Jakob Bunkenborg,et al.  A Proteomic Analysis of Human Hemodialysis Fluid*S , 2005, Molecular & Cellular Proteomics.

[28]  Mark Yandell,et al.  A computational and experimental approach to validating annotations and gene predictions in the Drosophila melanogaster genome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Dujon,et al.  Genome evolution in yeasts , 2004, Nature.

[30]  Lee H. Harrison,et al.  Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program , 2004, Journal of Clinical Microbiology.

[31]  Manimozhiyan Arumugam,et al.  Identification of rat genes by TWINSCAN gene prediction, RT-PCR, and direct sequencing. , 2004, Genome research.

[32]  F. Sherman,et al.  N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. , 2003, Journal of molecular biology.

[33]  D. Kontoyiannis,et al.  The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. , 2002, The American journal of medicine.

[34]  A. Barnes,et al.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. , 2002, The Journal of hospital infection.

[35]  A. Pandey,et al.  A reassessment of the translation initiation codon in vertebrates. , 2001, Trends in genetics : TIG.

[36]  U. Reichard,et al.  Secreted Aspartic Proteinase Family ofCandida tropicalis , 2001, Infection and Immunity.

[37]  M. Mann,et al.  Use of mass spectrometry-derived data to annotate nucleotide and protein sequence databases. , 2001, Trends in biochemical sciences.

[38]  M. Mann,et al.  Proteomics to study genes and genomes , 2000, Nature.

[39]  B. Lebeau,et al.  Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  G. Gilfillan,et al.  Candida dubliniensis: phylogeny and putative virulence factors. , 1998, Microbiology.

[41]  S. Špánik,et al.  Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. , 1998, The Journal of antimicrobial chemotherapy.

[42]  M. Borodovsky,et al.  GeneMark.hmm: new solutions for gene finding. , 1998, Nucleic acids research.

[43]  A. Podtelejnikov,et al.  Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Ghannoum,et al.  Evidence implicating phospholipase as a virulence factor of Candida albicans , 1995, Infection and immunity.

[45]  B. Hube,et al.  Multiplicity of genes encoding secreted aspartic proteinases in Candida species , 1994, Molecular microbiology.

[46]  P. T. Magee,et al.  The genes encoding the secreted aspartyl proteinases of Candida albicans constitute a family with at least three members , 1993, Infection and immunity.

[47]  J. L. Goodman,et al.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.

[48]  Y. Banno,et al.  Secreted Candida albicans phospholipases: purification and characterization of two forms of lysophospholipase-transacylase. , 1991, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[49]  M. Takashi.  Secreted Candida albicans phospholipases : purification and characterization of two forms of lysophospholipase-transacylase , 1991 .

[50]  J. F. Ryley,et al.  A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. , 1985, Journal of general microbiology.

[51]  Y. Banno,et al.  Secreted phospholipases of the dimorphic fungus, Candida albicans; separation of three enzymes and some biological properties. , 1985, Sabouraudia.

[52]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.